A nationwide Guillain–Barré syndrome epidemiological study in Spain during the COVID‐19years

• Published in: European journal of neurology Vol. 31; no. 12
• Main Authors: Marina Blanco‐Ruiz, Lorena Martín‐Aguilar, Marta Caballero‐Ávila, Lleixà, Cinta, Elba Pascual‐Goñi, Roger Collet‐Vidiella, Clara Tejada‐Illa, Janina Turon‐Sans, Carbayo, Álvaro, Llansó, Laura, Cortés, Elena, Laura Amaya Pascasio, Querol, Luis
• Format: Journal Article
• Language: English
• Published: Oxford John Wiley & Sons, Inc 01.12.2024
• Subjects: Coronaviruses; COVID-19; Epidemiology; Guillain-Barre syndrome; Observational studies; Older people; Pandemics; Respiratory diseases; Seasonal variations; Severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; Viral diseases; Spain
• ISSN: 1351-5101; 1468-1331
• DOI: 10.1111/ene.16439

Background and purposeThe purpose was to perform a nationwide epidemiological study of Guillain–Barré syndrome (GBS) in Spain, analysing background incidences and seasonal variation and trying to identify incidence changes during the coronavirus disease 2019 (COVID‐19) years.MethodsThis was an observational study collecting all GBS diagnoses from the National Epidemiological Surveillance Network collected by the Ministry of Health. Patients discharged with GBS as the main diagnosis and admitted during 2018–2021 were included. Data on the incidence of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infections were obtained from the National Epidemiology Centre.ResultsIn total, 3147 cases were included, 832 in 2018, 861 in 2019, 670 in 2020 and 784 in 2021. Nationwide hospital incidence was 1.78 in 2018, 1.71 in 2019, 1.41 in 2020 and 1.66 in 2021, with an increased frequency in males, the elderly population and in the winter season. Eleven per cent of GBS patients needed ventilatory support. GBS and SARS‐CoV‐2 incidences did not correlate with one another (r = −0.29, p = 0.36). GBS incidence decreased during 2020 and during the COVID‐19 lockdown period in comparison to the same months of 2018–2019.ConclusionsThe incidence of GBS in Spain is similar to that of other countries. Despite prior reports describing a significant increase in COVID‐19‐associated GBS in Spain, a significant drop of GBS incidence during the SARS‐CoV‐2 pandemic was detected, probably due to prevention measures.